The EMpulse is a 3.5-ounce device that uses nanotechnology to produce a specifically designed electromagnetic pulse to help stimulate healing. The device can fit in a shirt pocket and can be operated by batteries, electricity, or via a car cigarette lighter adapter. According to Gordon, it works by correcting the alignment of free radicals and antioxidants; when properly aligned, the antioxidants neutralize free radicals that control pain and expand injury and illness.

The EMpulse is approved by the Federal Drug Administration for several uses, and has additional off-label uses that can be applied under the supervision of a physician. A yearlong study on soldiers in Iraq demonstrated its efficiency in treating local trauma, and has prompted continuous interest from the Department of Defense for more studies, including for use in intermediate and massive trauma, Gordon said.

The company is hoping to receive some federal funding, and Gordon has the support of Washington’s congressional delegation to apply for a $2 million research grant in 2008 and another $3 million in 2009.

On the civilian side, EM-PROBE Technologies has been in discussions with several companies, including abroad, regarding licensing the technology and possibly even manufacturing. Among them are EMPI, a leading manufacturer of noninvasive medical products used for physical rehabilitation, and North American Rescue Products Inc.

If the company expands, it may remain in North Kitsap, Gordon said. “A research facility could employ 100 to 200 people,” he said.

The biggest challenge for EM-PROBE is lack of adequate financing to meet the market opportunities. Gordon estimates it would take a $10 million to $20 million investment and they are not “quite there yet.” Still, the company has been profitable since 2004, and is worth several millions — so he said growth is “a matter of when can we get finances to meet the market opportunities we are receiving every day.” The company is not after venture capital, but if funding develops through investors or licensing, they are prepared to move quickly, Gordon said.

In the meantime, EM-PROBE is close to its next step — a new device that is a pad covering a much larger area than the hand-held EMpulse. Future plans also call for the development of a whole-body device.

Pulsed electromagnetic field (PEMF) technology is not unique to EM-PROBE and has been used for years in Eastern Europe. Studies by NASA and other researchers have shown that nanosecond-level energy provides efficient injury and trauma treatment. According to EM-PROBE, the EMpulse is the most portable and least expensive PEMF therapy device on the market. The company uses 75 commissioned resellers and also sells the product on its Web site (www.em-probe.com). Locally, it’s available at the Poulsbo Drug Store Inc. on Front Street.

“People are so disheartened with drugs and surgery and are longing for less invasive interventions,” Gordon said. “I think that’s why lots of people have supported us.”.